Results 11 to 20 of about 32,135 (260)

Association between Glycosylated Hemoglobin Levels and Vaccine Preventable Diseases: A Systematic Review [PDF]

Diseases (Basel, Switzerland)
Annalisa Saracino, Stefania Maggi, Nicola Veronese   +2 more
exaly   +2 more sources

Genomic Insights on Variation Underlying Capsule Expression in Meningococcal Carriage Isolates From University Students, United States, 2015–2016

Frontiers in Microbiology, 2022
In January and February 2015, Neisseria meningitidis serogroup B (NmB) outbreaks occurred at two universities in the United States, and mass vaccination campaigns using MenB vaccines were initiated as part of a public health response.
Melissa J. Whaley, Jeni T. Vuong, Nadav Topaz, How-Yi Chang, Jennifer Dolan Thomas, Laurel T. Jenkins, Fang Hu, Susanna Schmink, Evelene Steward-Clark, Marsenia Mathis, Lorraine D. Rodriguez-Rivera, Adam C. Retchless, Sandeep J. Joseph, Alexander Chen, Anna M. Acosta, Lucy McNamara, Heidi M. Soeters, Sarah Mbaeyi, Henju Marjuki, Xin Wang   +19 more
doaj   +1 more source

Impact of National Immunization Strategies on Vaccine-Preventable Diseases — China, 1950–2021 [PDF]

China CDC Wkly
Zundong Yin
exaly   +2 more sources

ERADICATION OF VACCINE-PREVENTABLE DISEASES [PDF]

Annual Review of Public Health, 1999
▪ Abstract  Eradication is the permanent reduction to zero of the worldwide incidence of infection caused by a specific agent as a result of deliberate efforts; intervention measures are no longer needed. To date, the only infectious disease that has been eradicated is smallpox.
openaire   +2 more sources

Culture-Confirmed Invasive Meningococcal Disease in Canada, 2010 to 2014: Characterization of Serogroup B Neisseria meningitidis Strains and Their Predicted Coverage by the 4CMenB Vaccine

mSphere, 2020
The molecular epidemiology of culture-confirmed invasive meningococcal disease (IMD) in Canada from 2010 to 2014 was studied with an emphasis on serogroup B Neisseria meningitidis (MenB) isolates, including their predicted coverage by the 4CMenB vaccine.
Raymond S. W. Tsang, Dennis K. S. Law, Rosita De Paola, Maria Giuliani, Maria Stella, Jianwei Zhou, Saul Deng, Giuseppe Boccadifuoco, Marzia Monica Giuliani, Laura Serino   +9 more
doaj   +1 more source

COVID-19 vaccine-related adverse events following immunization in the WHO Western Pacific Region, 2021–2022

Western Pacific Surveillance and Response, 2023
The speed at which new vaccines against coronavirus disease (COVID-19) were developed and rolled out as part of the global response to the pandemic was unprecedented.
Ananda Amarasinghe, Heeyoun Cho, Eve Rizza Katalbas, Yoshihiro Takashima   +3 more
doaj   +1 more source

Factors associated with COVID-19 vaccine uptake in adolescents: a national cross-sectional study, August 2021–January 2022, England

BMJ Open, 2023
Objectives To assess socioeconomic and geographical factors associated with COVID-19 vaccine uptake in pupils attending state-funded secondary schools in England.Design Cross-sectional observational study.Setting State-funded schools in England ...
, Shamez N Ladhani, Alex Lewin, Mary E Ramsay, Charlotte Warren-Gash, Liang-Yu Lin, Sarah Cook, Joanne Beckmann, Ifeanyichukwu O Okike, Andrew Brent, Felicity Aiano, Joanna Garstang, Jody Phelan, Shazaad Ahmad, Ian Diamond, Colin N J Campbell, Punam Mangtani, Patrick Nguipdop-Djomo, Georgina Ireland, Pete Jones, Gillian McKay, Annabel Powell, Frances Baawuah, Emma Rourke, Alison Judd, Byron Davies, Anisah Saib, Bernadette Brent, Kevin E Brown, James McCrae, Joe Kelly, Dylan Stocker, Fiona Dawe, Elliot McClenahan   +33 more
doaj   +1 more source

Responding to COVID-19 vaccine-related safety events: WHO Western Pacific regional experience and lessons learned

Western Pacific Surveillance and Response, 2023
Problem: Novel vaccines were developed in an unprecedentedly short time in response to the global coronavirus disease (COVID-19) pandemic, which triggered concerns about the safety profiles of the new vaccines.
Heeyoun Cho, Ananda Amarasinghe, Yoshihiro Takashima   +2 more
doaj   +1 more source

Whole genome sequencing for investigations of meningococcal outbreaks in the United States: a retrospective analysis

Scientific Reports, 2018
Although rare in the U.S., outbreaks due to Neisseria meningitidis do occur. Rapid, early outbreak detection is important for timely public health response. In this study, we characterized U.S.
Melissa J. Whaley, Sandeep J. Joseph, Adam C. Retchless, Cecilia B. Kretz, Amy Blain, Fang Hu, How-Yi Chang, Sarah A. Mbaeyi, Jessica R. MacNeil, Timothy D. Read, Xin Wang   +10 more
doaj   +1 more source

Genetic Features of a Representative Panel of 110 Meningococcal B Isolates to Assess the Efficacy of Meningococcal B Vaccines

mSphere, 2022
Predictions of vaccine efficacy against Neisseria meningitidis serogroup B (NmB) disease are hindered by antigenic variability, limiting the representativeness of individual NmB isolates.
Alessandro Muzzi, Margherita Bodini, Nadav Topaz, Vega Masignani, Kumaran Vadivelu, Henju Marjuki, Xin Wang, Laura Serino, Duccio Medini   +8 more
doaj   +1 more source